Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of iron overload

C Hershko1, G Link, I Cabantchik

  • 1Department of Medicine, Shaare Zedek Medical Center, Hebrew University Hadassah Medical School, Jerusalem, Israel.

Annals of the New York Academy of Sciences
|July 21, 1998
PubMed
Summary

Thalassemia causes iron overload through excess absorption and transfusions. Non-transferrin-plasma iron (NTPI) is toxic, damaging cells and leading to heart issues; continuous chelation therapy is recommended.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cystocele and perineal ultrasound : Comparison of reliability and patient satisfaction].

Der Urologe. Ausg. A·2016
Same author

Photoregulation of psbA transcript levels in mustard cotyledons.

Photosynthesis research·2014
Same author

The ribosomal RNA genes from chloroplasts of mustard (Sinapis alba L.): mapping and sequencing of the leader region.

Plant molecular biology·2013
Same author

Hybridization study of developmental plastid gene expression in mustard (Sinapsis alba L.) with cloned probes for most plastid DNA regions.

Plant molecular biology·2013
Same author

Small RNA species in maize tissue.

Planta·2013
Same author

Enhanced expression of a distinct plastid DNA region in mustard seedlings by continuous far-red light.

Planta·2013

Area of Science:

  • Hematology
  • Cardiology
  • Biochemistry

Background:

  • Thalassemia leads to iron overload from increased absorption and transfusions.
  • Ineffective erythropoiesis in thalassemia dramatically increases plasma iron turnover.
  • Excess iron forms toxic non-transferrin-plasma iron (NTPI), causing cellular damage.

Purpose of the Study:

  • To investigate the toxicity and management of non-transferrin-plasma iron (NTPI) in thalassemia.
  • To evaluate the role of ascorbate and iron chelators in managing iron overload.
  • To determine optimal chelation therapy strategies for thalassemia patients.

Main Methods:

  • Analysis of iron metabolism and NTPI formation in thalassemia.
  • Assessment of NTPI's pro-oxidant activity and cellular damage.
  • Evaluation of intravenous deferoxamine (DFO) and bidentate chelators (L1) in iron removal.

Main Results:

  • NTPI promotes hydroxyl radical formation and peroxidative damage, particularly in the heart.
  • NTPI contributes to mitochondrial dysfunction and hemosiderotic cardiomyopathy.
  • Continuous intravenous DFO effectively removes NTPI, which reappears rapidly after cessation.

Conclusions:

  • NTPI is a key mediator of iron toxicity in thalassemia, leading to cardiac complications.
  • Continuous chelation therapy is superior to intermittent use for managing NTPI.
  • Ascorbate's role requires careful concentration management to avoid pro-oxidant effects; bidentate chelators may form incomplete complexes.

Related Experiment Videos